Particularly large increases were seen for American Indian or Alaska Native and Black individuals
Global Adult Mortality Rates Increased During COVID-19
Increase seen during pandemic period, following decrease between 1950 and 2019; child mortality continued to drop during pandemic
Changes Seen in Mortality Patterns Among Hispanic Groups in Pandemic
Two-year cumulative age- and sex-adjusted mortality risks varied from 1.1 to 2.0 percent for South, Central American groups during pandemic
Delayed Melanoma Care During Pandemic Proved Costly
Delayed diagnoses due to pandemic lockdowns tied to years of life lost
Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib
Baricitinib plus remdesivir linked to reduced risk of death, progression to invasive mechanical ventilation
Women Have Greater Mortality With Alcohol-Related Liver Disease
Findings persist across steatotic liver disease phenotypes
Declines in CVD Mortality Seen From 2010 to 2019 Reversed in 2020
From 2020 to 2022, there were 228,524 excess CVD deaths, which was 9 percent more than expected based on earlier trends
2020 to 2021 Saw Nonsignificant Decline in Perinatal Mortality Rate
Late fetal mortality rate was essentially unchanged, while early neonatal mortality rate decreased 4 percent
People With Severe Mental Illness Experienced Increased COVID-19 Mortality
Risk for death was found to be exacerbated by comorbidities
In-Hospital Mortality Evaluated for SARS-CoV-2-Linked Sepsis
March 2020 to November 2022 saw decline in crude in-hospital mortality for SARS-CoV-2-linked sepsis from 33.4 to 14.9 percent